$1 Trillion in Interest. Equities Are Priced Like It Doesn’t Exist.
The U.S. is now spending more on debt service than on national defense. Markets haven't connected those dots.
General
The GLP-1 Story Just Got a Second Act
Oral pills, Medicare coverage, and a triple-hormone drug showing bariatric-level weight loss. LLY is not done.
The Metal AI Can’t Run Without
Copper just hit record highs near $13,800 a tonne. The stocks mining it haven't fully caught up.
Salesforce Is Down 33% in 2026. That Might Be the Whole Point.
CRM is quietly becoming something different — and the market hasn't priced it in yet.
The $1.5 Trillion War Chest: Defense Stocks Are Back — But Are You Buying the Right Ones?
NATO rearmament, Middle East operations, and a record U.S. defense budget have defense names flying. The primes look crowded. The…
Quantum Computing Stocks Are Back. The $931 Million Warning Tells You Everything.
IonQ, Rigetti, and D-Wave are surging again – but insider behavior is flashing a signal the headlines aren't covering.
Micron Is Coiling Into June 24 Earnings — Watch These Levels
MU has surged over 200% YTD, Wolfe Research just raised its target to $1,250, and Q3 fiscal 2026 earnings drop…
Anthropic’s Near-Trillion Dollar IPO Filing Is Repricing Everything. Here’s What Investors Actually Own.
The Claude maker confidentially filed its S-1 at a $965B valuation. The real story isn't Anthropic — it's what this…
Apple Fell 5% at WWDC. Nvidia Quietly Won the Week. Here’s What the Options Market Sees Next.
AAPL slid while NVDA notched a stealth victory — and the divergence between their options flows tells the real story.
The Healthcare Sector Has Been Left for Dead. That’s the Setup Bargain Hunters Have Been Waiting For.
Three years of underperformance, a 20% valuation discount, and a mean-reversion case that's getting harder to ignore.